Oncology & Cancer

XL-184 (Cabozantinib) goes 12-for-12 in colorectal cancer explants

The novel c-MET and VEGFR2 inhibitor, XL-184 (Cabozantinib), resulted in a significant decrease in tumor growth in 12 out of 12 colorectal cancer (CRC) patient-derived explants, with 8 of the explants exhibiting stable disease. ...

Medications

Deaths tied to painkillers rising in the US

Despite efforts by law enforcement and public health officials to curb prescription drug abuse, drug-related deaths in the United States have continued to rise, the latest data show.

Oncology & Cancer

Cancer patient gets new lease on life through clinical trial

Arizona resident Evelyn Sorensen is in a far different place today than she was six months ago, thanks to a cutting-edge cancer clinical trial being conducted at the Virginia G. Piper Cancer Center at Scottsdale Healthcare ...

Oncology & Cancer

'Microbeads' may boost survival in advanced colon cancer patients

(HealthDay News) —For advanced colon cancer patients who have developed liver tumors, so-called "radioactive beads" implanted near these tumors may extend survival nearly a year longer than among patients on chemotherapy ...

Oncology & Cancer

Scientists pinpoint gene likely to promote childhood cancers

Researchers at the Children's Medical Center Research Institute at UT Southwestern (CRI) have identified a gene that contributes to the development of several childhood cancers, in a study conducted with mice designed to ...

page 38 from 40